2',3'-DIDEHYDRO-2',3'-DIDEOXY-5-CHLOROCYTIDINE IS A SELECTIVE ANTI-RETROVIRUS AGENT

被引：7
作者：
BALZARINI, J
VANAERSCHOT, A
HERDEWIJN, P
DECLERCQ, E
机构：
来源：
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 1989年 / 164卷 / 03期
关键词：
D O I：
10.1016/0006-291X(89)91795-6
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1190 / 1197
页数：8
相关论文
共 22 条
[1]   BOTH 2',3'-DIDEOXYTHYMIDINE AND ITS 2',3'-UNSATURATED DERIVATIVE (2',3'-DI-DEOXYTHYMIDINENE) ARE POTENT AND SELECTIVE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS-REPLICATION INVITRO [J].
BABA, M ;
PAUWELS, R ;
HERDEWIJN, P ;
DECLERCQ, E ;
DESMYTER, J ;
VANDEPUTTE, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 142 (01) :128-134
[2]   SELECTIVE-INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) BY 3'-AZIDO-2',3'-DIDEOXYGUANOSINE INVITRO [J].
BABA, M ;
PAUWELS, R ;
BALZARINI, J ;
HERDEWIJN, P ;
DECLERCQ, E .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 145 (03) :1080-1086
[3]   THE 2',3'-DIDEOXYRIBOSIDE OF 2,6-DIAMINOPURINE SELECTIVELY INHIBITS HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) REPLICATION INVITRO [J].
BALZARINI, J ;
PAUWELS, R ;
BABA, M ;
ROBINS, MJ ;
ZOU, R ;
HERDEWIJN, P ;
DECLERCQ, E .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 145 (01) :269-276
[4]   POTENT AND SELECTIVE ANTI-HTLV-III/LAV ACTIVITY OF 2',3'-DIDEOXYCYTIDINENE, THE 2',3'-UNSATURATED DERIVATIVE OF 2',3'-DIDEOXYCYTIDINE [J].
BALZARINI, J ;
PAUWELS, R ;
HERDEWIJN, P ;
DECLERCQ, E ;
COONEY, DA ;
KANG, GJ ;
DALAL, M ;
JOHNS, DG ;
BRODER, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 140 (02) :735-742
[5]   5-CHLORO-SUBSTITUTED DERIVATIVES OF 2',3'-DIDEHYDRO-2',3'-DIDEOXYURIDINE, 3'-FLUORO-2',3'-DIDEOXYURIDINE AND 3'-AZIDO-2',3'-DIDEOXYURIDINE AS ANTI-HIV AGENTS [J].
BALZARINI, J ;
VANAERSCHOT, A ;
HERDEWIJN, P ;
DECLERCQ, E .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (06) :869-874
[6]  
BALZARINI J, 1987, MOL PHARMACOL, V32, P162
[7]  
BALZARINI J, 1988, DEV MED VIROLOGY CLI, P361
[8]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[9]   COMPARATIVE ACTIVITY OF 2',3'-SATURATED AND UNSATURATED PYRIMIDINE AND PURINE NUCLEOSIDES AGAINST HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS [J].
CHU, CK ;
SCHINAZI, RF ;
ARNOLD, BH ;
CANNON, DL ;
DOBOSZEWSKI, B ;
BHADTI, VB ;
GU, ZP .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (19) :3543-3548
[10]   LONG-TERM PERSISTENT INFECTION OF MACAQUE MONKEYS WITH THE SIMIAN IMMUNODEFICIENCY VIRUS [J].
DANIEL, MD ;
LETVIN, NL ;
SEHGAL, PK ;
HUNSMANN, G ;
SCHMIDT, DK ;
KING, NW ;
DESROSIERS, RC .
JOURNAL OF GENERAL VIROLOGY, 1987, 68 :3183-3189
123